Bulletin
Investor Alert

Market Pulse Archives

Oct. 5, 2015, 5:17 p.m. EDT

Haemonetics shares fall after outlook cut

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Haemonetics Corp. (HAE)

or Cancel Already have a watchlist? Log In

By Wallace Witkowski

HAE

Haemonetics Corp. /zigman2/quotes/205816408/composite HAE +3.90% shares dropped in the extended session Monday after the company cut its outlook for the year. Haemonetics shares fell 12% to $29.29. The company, which specializes in blood-component collection and transfusion devices and services, cut its full-year forecast earnings range to $1.65 and $1.75 a share, from a previous range of $1.98 and $2.08 a share, on revenue of $910 million to $920 million. Analysts surveyed by FactSet had forecast $2.02 a share on revenue of $946.8 million.

/zigman2/quotes/205816408/composite
US : U.S.: NYSE
$ 65.26
+2.45 +3.90%
Volume: 1.01M
June 24, 2022 4:00p
P/E Ratio
77.38
Dividend Yield
N/A
Market Cap
$3.35 billion
Rev. per Employee
$352,072
loading...

Get news alerts on Haemonetics Corp. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.